New treatments for systemic lupus erythematosus

New therapies for systemic lupus erythematosus are rare. This is because of the complexity of the disease and its varied presentations. There are many variables and a variety of measurement scales that must be satisfied before a new agent is approved for use in humans. Attempts are ongoing to develo...

Full description

Saved in:
Bibliographic Details
Main Author: Robert George Lahita
Format: Article
Language:English
Published: SAGE Publishing 2017-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=48;epage=51;aulast=Lahita
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561360007168000
author Robert George Lahita
author_facet Robert George Lahita
author_sort Robert George Lahita
collection DOAJ
description New therapies for systemic lupus erythematosus are rare. This is because of the complexity of the disease and its varied presentations. There are many variables and a variety of measurement scales that must be satisfied before a new agent is approved for use in humans. Attempts are ongoing to develop biological treatments for the disease using three approaches: B cell modulation, T cell regulation and cytokine inhibition. This paper reviews the current state of these three critical areas.
format Article
id doaj-art-c7ef360152734f6d93bf77f4e7b709ea
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2017-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-c7ef360152734f6d93bf77f4e7b709ea2025-01-03T01:45:40ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012017-01-01121485110.4103/injr.injr_1_17New treatments for systemic lupus erythematosusRobert George LahitaNew therapies for systemic lupus erythematosus are rare. This is because of the complexity of the disease and its varied presentations. There are many variables and a variety of measurement scales that must be satisfied before a new agent is approved for use in humans. Attempts are ongoing to develop biological treatments for the disease using three approaches: B cell modulation, T cell regulation and cytokine inhibition. This paper reviews the current state of these three critical areas.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=48;epage=51;aulast=LahitaB cellscytokine manipulationlupus treatmentsT cells
spellingShingle Robert George Lahita
New treatments for systemic lupus erythematosus
Indian Journal of Rheumatology
B cells
cytokine manipulation
lupus treatments
T cells
title New treatments for systemic lupus erythematosus
title_full New treatments for systemic lupus erythematosus
title_fullStr New treatments for systemic lupus erythematosus
title_full_unstemmed New treatments for systemic lupus erythematosus
title_short New treatments for systemic lupus erythematosus
title_sort new treatments for systemic lupus erythematosus
topic B cells
cytokine manipulation
lupus treatments
T cells
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=48;epage=51;aulast=Lahita
work_keys_str_mv AT robertgeorgelahita newtreatmentsforsystemiclupuserythematosus